Financial Performance - The company's revenue for Q3 2021 was ¥121,049,085.68, a decrease of 2.50% compared to the same period last year, and a year-to-date revenue of ¥512,869,188.98, down 38.85% year-on-year[4] - The net profit attributable to shareholders for Q3 2021 was ¥21,887,036.90, a decline of 61.58%, with a year-to-date net profit of ¥124,478,367.92, down 48.00% compared to the previous year[4] - The basic earnings per share for Q3 2021 was ¥0.0098, a decrease of 61.87%, with a year-to-date figure of ¥0.0556, down 48.47% year-on-year[4] - Total operating revenue for the current period is ¥512,869,188.98, a decrease of 38.7% compared to ¥838,759,369.84 in the previous period[30] - Net profit for the current period is ¥104,859,677.44, a decline of 55.0% from ¥233,504,193.20 in the previous period[33] - Earnings per share for the current period is ¥0.1079, compared to ¥0.1079 in the previous period[36] Assets and Liabilities - The company's total assets as of the end of Q3 2021 were ¥6,081,080,656.33, representing a decrease of 4.97% from the end of the previous year[4] - The company's current assets totaled CNY 3,569,312,979.07, down from CNY 4,799,418,955.30 at the end of 2020, indicating a decrease of about 25.66%[23] - Cash and cash equivalents decreased significantly from CNY 2,413,450,777.20 in December 2020 to CNY 1,234,238,991.95 by September 2021, a reduction of approximately 48.92%[20] - The total liabilities decreased from CNY 446,366,740.11 to CNY 411,964,759.52, a decline of approximately 7.68%[26] - Total liabilities amounted to 446,366,740.11, a decrease of 13,218,555.39 compared to the previous period[50] - Non-current liabilities totaled 33,339,286.91, reflecting a decrease from 40,794,194.80[50] Shareholder Information - The total number of common shareholders at the end of the reporting period is 47,246[11] - Meilin Holdings Group Limited holds 20.00% of shares, totaling 448,263,156 shares[11] - Shanghai Yueye Equity Investment Management Partnership holds 18.48% of shares, totaling 414,138,066 shares[11] - Xinjiang Kaidi Investment Limited Liability Company holds 18.28% of shares, totaling 409,748,445 shares[11] - The top ten shareholders collectively hold a significant portion of the company's shares, with the first three shareholders alone accounting for over 56%[11] - The company has a total of 0 preferred shareholders at the end of the reporting period[15] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥125,866,421.66, a significant decrease of 84.21% compared to the previous year[10] - Cash flow from operating activities is ¥741,567,155.95, significantly lower than ¥1,479,836,397.22 in the previous period[37] - Cash outflow from investing activities totaled $882.09 million, down from $2.45 billion, resulting in a net cash flow from investing activities of -$239.30 million[40] - Cash flow from financing activities showed a net outflow of -$473.24 million, compared to a net inflow of $27.69 million in the previous period[40] Expenses - Research and development expenses for the year-to-date period increased by 47.87% to ¥51,929,287.83, reflecting increased investment in R&D projects[10] - The company reported a decrease in sales expenses by 43.21% to ¥109,966,938.92, attributed to reduced product promotion costs[10] - The company reported a decrease in sales expenses to ¥109,966,938.92 from ¥193,651,609.36, reflecting cost-cutting measures[30] Strategic Changes - The company is undergoing a transition in its board of directors, with new appointments expected to influence future strategic directions[4] - The company has temporarily suspended cooperation on investment matters due to changes in its controlling shareholder, pending the establishment of a new board[4] - The company is focusing on expanding its market presence and exploring new investment opportunities in the carbon asset sector[4] Other Financial Metrics - The company's non-current assets increased to CNY 2,511,767,677.26 from CNY 1,600,024,517.87, representing a growth of about 56.88%[23] - The company has a minority interest loss of ¥19,618,690.48, compared to a loss of ¥5,895,417.17 in the previous period[33] - The company has not audited its third-quarter report[50] - The retained earnings were reported at 4,420,938,435.31, unchanged from the previous period[50]
德展健康(000813) - 2021 Q3 - 季度财报